Patents
Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979)
02/2009
02/11/2009CN101365692A Novel antifungal triazole derivatives
02/11/2009CN101365686A Heterocyclic derivatives as modulators of ion channels
02/11/2009CN101365685A 2-(benzimidazol-1-yl)-acetamide biaryl derivatives and their use as inhibitors of the TRPV1 receptor
02/11/2009CN101365682A Bicyclic compounds with kinase inhibitory activity
02/11/2009CN101365680A 3,5-substituted piperidine compounds as renin inhibitors
02/11/2009CN101365678A Modulators of the h3 receptor useful for the treatment of disorders related thereto
02/11/2009CN101365676A Azetidines as mek inhibitors for the treatment of proliferative diseases
02/11/2009CN101364636A Organic electroluminescent device
02/11/2009CN101362749A Sertindole synthesis method
02/11/2009CN101362748A Method for preparing sertindole
02/11/2009CN101362747A Functional ino liquid containing bidentate nitrogen ligands and synthesis method thereof
02/11/2009CN101362746A Separation method of argatroban single stereoisomers and polymorph
02/11/2009CN101362731A Heterocyclic compounds and methods of use
02/11/2009CN100460391C Chemical compounds.
02/10/2009US7488824 Process for the production of substituted nicotinic acid esters
02/10/2009US7488823 4-anilino quinazolines substituted with a N'-cyanoguanidinoalkyl group; antiproliferative, anticancer, antiinflammatory
02/10/2009US7488748 3,6-Disubstituted azabicyclo hexane derivatives as muscarinic receptor antagonists
02/10/2009US7488744 Indole-type derivatives as inhibitors of p38 kinase
02/10/2009US7488743 Indolin-2-one pyridine derivatives, preparation and therapeutic use thereof
02/10/2009US7488740 Substituted quinolin-4-ylamine analogues
02/10/2009US7488738 Such as 4-({4-[[(4-Amino-2,3,5,6-tetramethylanilino)acetyl]-(methyl)amino]-1-piperidino}methyl)benzamide which has neuroprotective effects by inducing calcium binding proteins
02/10/2009US7488737 Each compound having an azabicyclic ring attached via a ring N or amino group; neuroprotectants; neurodegenerative diseases, analgesics, psychological disorders; e.g. 5-Methoxy-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxamide; ligands for nicotinic acetylcholine receptors
02/10/2009US7488733 For improving perception, concentration, learning or memory; 2-(Cyclopentylmethyl)-4-[(fluorophenyl)amino]6-oxo-1,6-dihydro-5-pyrimidinecarbonitrile; amination of methyl 2-cyano propenoate derivatives, cyclization using amidinehydrochloride derivatives
02/10/2009US7488731 Arylpiperazinyl compounds
02/10/2009US7488725 To treat diabetes, especially type II diabetes including complications of diabetes; synergistic
02/10/2009US7488497 Oral pharmaceutical dosage forms comprising a proton pump inhibitor and a NSAID
02/10/2009US7488468 Water solubility, reduced toxicity; photodynamic therapy; administering near infrared fluorescent contrast agent , exposing to an excitation light, and detecting near infrared fluorescence from the contrast agent
02/10/2009CA2451229C Indole derivatives
02/10/2009CA2346988C Pharmaceutical formulation comprising omeprazole
02/10/2009CA2336691C Ligands for metals and metal-catalyzed processes
02/10/2009CA2208671C Substituted imides as tnf inhibitors
02/10/2009CA2189044C Acylated aminophenylsulfonylureas, processes for their preparation and their use as herbicides and plant growth regulators
02/10/2009CA2186511C Pyrimidinyl derivatives as interleukin inhibitors
02/05/2009WO2009017951A2 Pesticides and uses thereof
02/05/2009WO2009017288A1 Process for preparation of disodium stilbenedisulfonates
02/05/2009WO2009017219A1 Inhibitor of binding of s1p1
02/05/2009WO2009016498A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
02/05/2009WO2009016460A2 Pyrazole compounds and their use as raf inhibitors
02/05/2009WO2009016253A2 Cyanomethyl substituted n-acyl tryptamines
02/05/2009WO2009016227A2 Novel compounds
02/05/2009WO2009016225A1 1-piperidinyl-6-piperidinylsulfonylindoles as 5-ht (2b) receptor antagonists
02/05/2009WO2009016221A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
02/05/2009WO2009016219A1 Fungicide 2-pyridyl-methylene-thio carboxamide or 2-pyridyl-methylene-n-substituted carboximidamide derivatives
02/05/2009WO2009016216A1 Triazole derivatives as scd inhibitors
02/05/2009WO2009015897A1 Novel heterocyclic compounds as mglu5 antagonists
02/05/2009WO2009015867A1 Substituted aryl or heteroarylpiperdine derivatives as melanocortin-4 receptor modulators
02/05/2009WO2008135826A3 2 -pyridine carboxamide derivatives as sodium channel modulators
02/05/2009WO2008129054A3 Heterocyclic compounds with affinity to muscarinic receptors
02/05/2009WO2008128919A3 Histamine h3 receptor ligands comprising a cyclobutoxy group
02/05/2009WO2008125691A3 Ethers of naphtalene carboxylic acid amides as cancer cure
02/05/2009WO2008125295A3 Novel vanilloid receptor ligands, and their use for the production of pharmaceuticals
02/05/2009WO2008124703A3 Development of molecular imaging probes for carbonic anhydrase-ix using click chemistry
02/05/2009WO2003099808A8 Substituted heterocyclic compounds and methods of use
02/05/2009US20090036686 Preparation and use of 2-substituted-5-oxo-3-pyrazolidinecarboxylates
02/05/2009US20090036685 Process for Producing Imidazothiazole Derivatives
02/05/2009US20090036682 Crystalline form of 8-(4-Methyl-piperazin-1-yl)-3-phenylsulfonylquinoline; used in the treatment of CNS and other disorders
02/05/2009US20090036676 Bicyclic heterocyclic compounds, pharmaceutical compositions containing these compounds, their use and process for preparing them
02/05/2009US20090036493 Benzimidazole Derivatives and Their Use for Modulating the GABA Alpha Receptor Complex
02/05/2009US20090036489 Novel Cyclic Aminophenylalkanoic Acid Derivative
02/05/2009US20090036476 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
02/05/2009US20090036475 Pyrazolyl-Pyrimidines as Potassium Channel Modulating Agents and Their Medical Use
02/05/2009US20090036469 2,6-substituted-4-monosubstituted amino-pyrimidine as prostaglandin d2 receptor antagonists
02/05/2009US20090036466 Amino-benzimidazoles derivatives as inhibitors of respiratory syncytial virus replication
02/05/2009US20090036459 Melanocortin Type 4 Receptor Agonist Piperidinoylpyrrolidines
02/05/2009US20090036457 Utilities of olefin derivatives
02/05/2009US20090036452 Taar1 ligands
02/05/2009US20090036448 Pyrimidine derivatives and methods of treatment related to the use thereof
02/05/2009US20090036447 Compounds, Compositions and Methods
02/05/2009US20090036442 N-aroyl cyclic amine derivatives as orexin receptor antagonists
02/05/2009US20090036441 Indole Derivatives With Antitumor Activity
02/05/2009US20090036438 Five-membered heterocycles useful as serine protease inhibitors
02/05/2009US20090036436 3-aryl-3-hydroxy-2-amino-propionic acid amides, 3-heteroaryl-3-hydroxy-2-amino-propionic acid amides and related compounds having analgesic and/or immuno stimulant activity
02/05/2009US20090036434 Substituted aryl and heteroaryl derivatives as modulators of metabolism and the prophylaxis and treatment of disorders related thereto
02/05/2009US20090036429 Hydroxypiperidine Derivatives and Uses Thereof
02/05/2009US20090036421 Pyrrole Derivative or Salt Thereof
02/05/2009US20090036420 Benzamide derivatives and their use for treating cns disorders
02/05/2009US20090036412 Methods and Compositions for Inhibition of Angiogenesis
02/05/2009US20090036310 Substituted 1-(3-pyridinyl)pyrazol-4-ylacetic Acids, Processes for Their Preparation and Their Use as Herbicides and Plant Growth Regulators
02/05/2009US20090035309 Substituted Benzazoles and Methods of Their Use as Inhibitors of RAF Kinase
02/05/2009US20090035306 Quinazolinone modulators of tgr5
02/05/2009US20090035267 Acyclic, pyridazinone-derived hepatitis c serine protease inhibitors
02/05/2009US20090035219 CB1 receptor antagonists and uses thereof
02/05/2009US20090032106 N-type conjugated materials based on 2-vinyl-4,5-dicyanoimidazoles and their use in organic photovoltaics
02/05/2009CA2695496A1 N-piperidin-4-ylmethyl-amide derivatives and their use as monoamine neurotransmitter re-uptake inhibitors
02/05/2009CA2695304A1 Pyrimidine and pyridine derivatives and their pharmaceutical use and compositions
02/05/2009CA2695156A1 Vinyl-aryl derivatives for inflammation and immune-related uses
02/05/2009CA2695114A1 Pyrazole compounds and their use as raf inhibitors
02/05/2009CA2694359A1 Novel heterocyclic compounds as mglu5 antagonists
02/05/2009CA2692696A1 Fungicide n-6-membered fused (hetero)aryl-methylene-n-cycloalkyl carboxamide derivatives
02/05/2009CA2684889A1 Pesticides and uses thereof
02/04/2009EP2020409A1 New piperidinyl derivatives as modulators of chemokine receptor activity
02/04/2009EP2020405A1 Substituted aryl or heteroarylpiperidine derivatives as melanocortin-4 receptor modulators
02/04/2009EP2020404A1 Cyanomethyl substituted N-Acyl Tryptamines
02/04/2009EP2019825A1 Inhibitors of human immunodeficiency virus replication
02/04/2009EP1824817B1 Arylsulfonylnaphthalene derivatives as 5ht2a antagonists
02/04/2009EP1601653B1 Process for the production of substituted nicotinic acid esters
02/04/2009EP1492773B1 4-(heterocyclyl)-benzenesulfoximine compounds for the treatment of inflammation
02/04/2009CN101360739A Label-free optical sensing and characterization of biomolecules by d8 or d10 metal complexes
02/04/2009CN101360738A Compositions and methods for modulating gated ion channels
02/04/2009CN101360737A 2-amino-5-piperidinylimidazolone compounds and use thereof for (insert beta symbol)-secretase modulation